The GenScript SARS-CoV-2 Spike S1-RBD IgG&IgM ELISA Detection Kit is intended for the determination of IgG and IgM antibodies separately against SARS-CoV-2 Spike S1-Receptor Binding Domain (RBD) in human serum or plasma. The kit can be used to evaluate the immune efficacy of mRNA COVID-19 vaccines.
If you need kits to detect total antibodies (including IgA, IgM and IgG) against RBD and N protein or evaluate the immune efficacy of inactivated vaccines, you can learn about SARS-CoV-2 NP&RBD Total Antibody ELISA Kit (GenScript, L00846)
For Research Use Only. Not for Use in Diagnostic Procedures. The operator should read technical manual carefully before using this product.
known level of control was spiked into sample buffer as a test sample. The
sample was tested 10 times on the same plate to evaluate intra-assay precision of the kit. Intra-assay variation of this kit is
less than or equal to 10%.
Inter-assay: One known level of control was spiked into sample buffer as a test sample. The sample was tested on 3 plates which were randomly selected from 3 different lots to evaluate inter-assay precision of the kit. Inter-assay variation of this kit is less than or equal to 15%.
|Storage||The unopened kit is stable for at least 12 months from the date of manufacture if stored at 2 to 8°C, and the opened kit is stable for up to 1 month from the date of opening at 2 to 8°C.|
For more documents, please visit "Technical Support".